Literature DB >> 16282040

Fibromyalgia: progress in diagnosis and treatment.

Dina Dadabhoy1, Daniel J Clauw.   

Abstract

Fibromyalgia is a frequent cause of chronic widespread pain and affects up to 5% of the general population. Diagnosis and treatment have been especially challenging due to limited knowledge of etiology and poor response to conventional treatment of pain. Appreciation for the interactions of neurobiologic, psychologic, and behavioral factors in the disease pathogenesis has led to improved treatment options that can be effective in individual patients. Current evidence advocates a multifaceted program emphasizing patient education, medications for improving symptoms, and aggressive use of exercise and cognitive-behavioral approaches to retain or restore function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282040     DOI: 10.1007/s11916-005-0019-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  46 in total

Review 1.  Present state of medication therapy in fibromyalgia syndrome.

Authors:  J Lautenschläger
Journal:  Scand J Rheumatol Suppl       Date:  2000

Review 2.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.

Authors:  D J Clauw; G P Chrousos
Journal:  Neuroimmunomodulation       Date:  1997 May-Jun       Impact factor: 2.492

3.  Risk factors for persistent chronic widespread pain: a community-based study.

Authors:  J McBeth; G J Macfarlane; I M Hunt; A J Silman
Journal:  Rheumatology (Oxford)       Date:  2001-01       Impact factor: 7.580

4.  Evidence of the dual mechanisms of action of venlafaxine.

Authors:  A T Harvey; R L Rudolph; S H Preskorn
Journal:  Arch Gen Psychiatry       Date:  2000-05

5.  A randomized controlled trial of citalopram in the treatment of fibromyalgia.

Authors:  Jesper Nørregaard; Helge Volkmann; Bente Danneskiold-Samstøe
Journal:  Pain       Date:  1995-06       Impact factor: 6.961

6.  Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels.

Authors:  J M Mountz; L A Bradley; J G Modell; R W Alexander; M Triana-Alexander; L A Aaron; K E Stewart; G S Alarcón; J D Mountz
Journal:  Arthritis Rheum       Date:  1995-07

7.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.

Authors:  I J Russell; H Vaeroy; M Javors; F Nyberg
Journal:  Arthritis Rheum       Date:  1992-05

8.  Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.

Authors:  J A Desmeules; C Cedraschi; E Rapiti; E Baumgartner; A Finckh; P Cohen; P Dayer; T L Vischer
Journal:  Arthritis Rheum       Date:  2003-05

9.  A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.

Authors:  Olivier Vitton; Michael Gendreau; Judy Gendreau; Jay Kranzler; Srinivas G Rao
Journal:  Hum Psychopharmacol       Date:  2004-10       Impact factor: 1.672

10.  Family study of fibromyalgia.

Authors:  Lesley M Arnold; James I Hudson; Evelyn V Hess; Avis E Ware; Deborah A Fritz; Megan B Auchenbach; Linsey O Starck; Paul E Keck
Journal:  Arthritis Rheum       Date:  2004-03
View more
  8 in total

Review 1.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

2.  Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia.

Authors:  Simone S Nascimento; Enilton A Camargo; Josimari M DeSantana; Adriano A S Araújo; Paula P Menezes; Waldecy Lucca-Júnior; Ricardo L C Albuquerque-Júnior; Leonardo R Bonjardim; Lucindo J Quintans-Júnior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-24       Impact factor: 3.000

Review 3.  Comorbidity of fibromyalgia and psychiatric disorders.

Authors:  Dan Buskila; Hagit Cohen
Journal:  Curr Pain Headache Rep       Date:  2007-10

4.  Characteristic electron microscopic findings in the skin of patients with fibromyalgia: preliminary study.

Authors:  Seong-Ho Kim; Dong Hoon Kim; Dong-Ho Oh; Daniel J Clauw
Journal:  Clin Rheumatol       Date:  2007-10-03       Impact factor: 2.980

5.  Characteristic electron microscopic findings in the skin of patients with fibromyalgia--preliminary study.

Authors:  Seong-Ho Kim; Dong Hoon Kim; Dong-Ho Oh; Daniel J Clauw
Journal:  Clin Rheumatol       Date:  2008-03       Impact factor: 2.980

6.  Chronic prostatitis: approaches for best management.

Authors:  Kyung Seop Lee; Jae Duck Choi
Journal:  Korean J Urol       Date:  2012-02-20

7.  Cyclodextrin-complexed Ocimum basilicum leaves essential oil increases Fos protein expression in the central nervous system and produce an antihyperalgesic effect in animal models for fibromyalgia.

Authors:  Simone S Nascimento; Adriano A S Araújo; Renan G Brito; Mairim R Serafini; Paula P Menezes; Josimari M DeSantana; Waldecy Lucca; Pericles B Alves; Arie F Blank; Rita C M Oliveira; Aldeidia P Oliveira; Ricardo L C Albuquerque; Jackson R G S Almeida; Lucindo J Quintans
Journal:  Int J Mol Sci       Date:  2014-12-29       Impact factor: 5.923

8.  Characteristics and healthcare costs of patients with fibromyalgia syndrome.

Authors:  A Berger; E Dukes; S Martin; J Edelsberg; G Oster
Journal:  Int J Clin Pract       Date:  2007-07-26       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.